文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌肿瘤推量勾画变异性对临床结局的影响

Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-06-24

本研究评估放射肿瘤科医生在前列腺癌局灶放疗推量中勾画肿瘤靶区的变异性对预测临床结局的影响。45名放射肿瘤科医生和2名专家放射科医生对30例患者进行勾画,其中8例纳入分析,共394个靶区。结果显示参与者计划预测的生化失败率平均绝对增加4.3%,37%的计划生化失败绝对增加≥5%。

要点

  • 放射肿瘤科医生勾画的前列腺肿瘤靶区常不准确,导致预测临床结局劣于专家。
  • 参与者计划预测的生化失败率平均绝对增加4.3%。
  • 37%的参与者计划生化失败绝对增加≥5%,被认为具有临床意义。

核心结论

  • 放射肿瘤科医生为局灶放疗推量勾画肿瘤靶区时常不准确,足以导致患者临床结局出现有意义的劣化。

研究设计与样本

  • 45名放射肿瘤科医生和2名专家放射科医生对30例患者病例的前列腺肿瘤进行勾画,选择有CT模拟或诊断CT的病例进行分析。
  • 开发基于知识的计划模型,按III期随机对照试验方案为每个勾画生成局灶放疗推量计划,并使用该试验的模型确定生化失败概率。
  • 主要评估指标为生化失败差值(DBF=参与者生化失败-专家生化失败),生化失败绝对增加≥5%被认为具有临床意义。

主要发现

  • 分析纳入8例患者病例和394个用于局灶放疗推量计划的目标体积。
  • 总体而言,与专家计划相比,参与者计划与更差的预测临床结局相关,生化失败平均绝对增加4.3%。
  • 37%的参与者计划生化失败绝对增加≥5%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The focal radiation therapy (RT) boost technique was shown in a phase III randomized controlled trial (RCT) to improve prostate cancer outcomes without increasing toxicity. This technique relies on the accurate delineation of prostate tumors on MRI. A recent prospective study evaluated radiation oncologists' accuracy when asked to delineate prostate tumors on MRI and demonstrated high variability in tumor contours. We sought to evaluate the impact of contour variability and inaccuracy on predicted clinical outcomes. We hypothesized that radiation oncologists' contour inaccuracies would yield meaningfully worse clinical outcomes. METHODS AND MATERIALS: Forty-five radiation oncologists and 2 expert radiologists contoured prostate tumors on 30 patient cases. Of these cases, those with CT simulation or diagnostic CT available were selected for analysis. A knowledge-based planning model was developed to generate focal RT boost plans for each contour per the RCT protocol. The probability of biochemical failure (BF) was determined using a model from the RCT. The primary metric evaluated was delta BF (DBF = Participant BF - Expert BF). An absolute increase in BF ≥5% was considered clinically meaningful. RESULTS: Eight patient cases and 394 target volumes for focal RT boost planning were included in this analysis. In general, participant plans were associated with worse predicted clinical outcomes compared to the expert plan, with an average absolute increase in BF of 4.3%. Of participant plans, 37% were noted to have an absolute increase in BF of 5% or more. CONCLUSIONS: Radiation oncologists' attempts to contour tumor targets for focal RT boost are frequently inaccurate enough to yield meaningfully inferior clinical outcomes for patients.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Zhong AY, Lui AJ, Kuznetsova S, et al. Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost. Int J Radiat Oncol Biol Phys. 2024. PMID: 38925224. doi:10.1016/j.ijrobp.2024.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。